FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4226483144> ?p ?o ?g. }

• W4226483144 endingPage "545" @default.
• W4226483144 startingPage "527" @default.
• W4226483144 abstract "Heparan sulfate (HS) is a cell surface polysaccharide recently identified as a coreceptor with the ACE2 protein for the S1 spike protein on SARS-CoV-2 virus, providing a tractable new therapeutic target. Clinically used heparins demonstrate an inhibitory activity but have an anticoagulant activity and are supply-limited, necessitating alternative solutions. Here, we show that synthetic HS mimetic pixatimod (PG545), a cancer drug candidate, binds and destabilizes the SARS-CoV-2 spike protein receptor binding domain and directly inhibits its binding to ACE2, consistent with molecular modeling identification of multiple molecular contacts and overlapping pixatimod and ACE2 binding sites. Assays with multiple clinical isolates of SARS-CoV-2 virus show that pixatimod potently inhibits the infection of monkey Vero E6 cells and physiologically relevant human bronchial epithelial cells at safe therapeutic concentrations. Pixatimod also retained broad potency against variants of concern (VOC) including B.1.1.7 (Alpha), B.1.351 (Beta), B.1.617.2 (Delta), and B.1.1.529 (Omicron). Furthermore, in a K18-hACE2 mouse model, pixatimod significantly reduced SARS-CoV-2 viral titers in the upper respiratory tract and virus-induced weight loss. This demonstration of potent anti-SARS-CoV-2 activity tolerant to emerging mutations establishes proof-of-concept for targeting the HS-Spike protein-ACE2 axis with synthetic HS mimetics and provides a strong rationale for clinical investigation of pixatimod as a potential multimodal therapeutic for COVID-19." @default.
• W4226483144 created "2022-05-05" @default.
• W4226483144 creator A5001216000 @default.
• W4226483144 creator A5001476122 @default.
• W4226483144 creator A5011516027 @default.
• W4226483144 creator A5013218544 @default.
• W4226483144 creator A5013718219 @default.
• W4226483144 creator A5016372355 @default.
• W4226483144 creator A5017805469 @default.
• W4226483144 creator A5019038889 @default.
• W4226483144 creator A5020871383 @default.
• W4226483144 creator A5021196744 @default.
• W4226483144 creator A5021371636 @default.
• W4226483144 creator A5021482755 @default.
• W4226483144 creator A5026852293 @default.
• W4226483144 creator A5028741605 @default.
• W4226483144 creator A5029246358 @default.
• W4226483144 creator A5031588979 @default.
• W4226483144 creator A5032774539 @default.
• W4226483144 creator A5033464384 @default.
• W4226483144 creator A5035772207 @default.
• W4226483144 creator A5038148203 @default.
• W4226483144 creator A5042133390 @default.
• W4226483144 creator A5047945338 @default.
• W4226483144 creator A5048025965 @default.
• W4226483144 creator A5050474841 @default.
• W4226483144 creator A5051710860 @default.
• W4226483144 creator A5053388943 @default.
• W4226483144 creator A5055221957 @default.
• W4226483144 creator A5060128386 @default.
• W4226483144 creator A5061208744 @default.
• W4226483144 creator A5061975612 @default.
• W4226483144 creator A5065030535 @default.
• W4226483144 creator A5065506726 @default.
• W4226483144 creator A5067048102 @default.
• W4226483144 creator A5067555659 @default.
• W4226483144 creator A5069308257 @default.
• W4226483144 creator A5072084139 @default.
• W4226483144 creator A5072766818 @default.
• W4226483144 creator A5077504448 @default.
• W4226483144 creator A5078509098 @default.
• W4226483144 creator A5078801352 @default.
• W4226483144 creator A5080600115 @default.
• W4226483144 creator A5083922647 @default.
• W4226483144 date "2022-03-29" @default.
• W4226483144 modified "2023-10-10" @default.
• W4226483144 title "Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike–ACE2 Interaction" @default.
• W4226483144 cites W1588979652 @default.
• W4226483144 cites W1968984443 @default.
• W4226483144 cites W1976499671 @default.
• W4226483144 cites W1979225185 @default.
• W4226483144 cites W1987195459 @default.
• W4226483144 cites W1991286340 @default.
• W4226483144 cites W2020722562 @default.
• W4226483144 cites W2038032151 @default.
• W4226483144 cites W2092785485 @default.
• W4226483144 cites W2095719702 @default.
• W4226483144 cites W2098943363 @default.
• W4226483144 cites W2103443709 @default.
• W4226483144 cites W2118233996 @default.
• W4226483144 cites W2130318026 @default.
• W4226483144 cites W2131851892 @default.
• W4226483144 cites W2144775933 @default.
• W4226483144 cites W2161605421 @default.
• W4226483144 cites W2164270482 @default.
• W4226483144 cites W2190711022 @default.
• W4226483144 cites W2313116527 @default.
• W4226483144 cites W2408591722 @default.
• W4226483144 cites W2598878487 @default.
• W4226483144 cites W2791160806 @default.
• W4226483144 cites W2793877715 @default.
• W4226483144 cites W2905661855 @default.
• W4226483144 cites W2907591880 @default.
• W4226483144 cites W2944020377 @default.
• W4226483144 cites W2953467281 @default.
• W4226483144 cites W3007092620 @default.
• W4226483144 cites W3009912996 @default.
• W4226483144 cites W3014099229 @default.
• W4226483144 cites W3015190630 @default.
• W4226483144 cites W3022107478 @default.
• W4226483144 cites W3023982717 @default.
• W4226483144 cites W3024057160 @default.
• W4226483144 cites W3025596973 @default.
• W4226483144 cites W3027913941 @default.
• W4226483144 cites W3033171357 @default.
• W4226483144 cites W3035080949 @default.
• W4226483144 cites W3037833988 @default.
• W4226483144 cites W3039901154 @default.
• W4226483144 cites W3045079087 @default.
• W4226483144 cites W3046069905 @default.
• W4226483144 cites W3080378920 @default.
• W4226483144 cites W3085153423 @default.
• W4226483144 cites W3087409770 @default.
• W4226483144 cites W3092332314 @default.
• W4226483144 cites W3096022792 @default.
• W4226483144 cites W3097878033 @default.
• W4226483144 cites W3099182481 @default.
• W4226483144 cites W3115315281 @default.

• next